- Filed
- Feb 14, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Stockholders Equity | Q2 2024 · Jun 30, 2024 | $4.78B |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | $3.69B |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $4.61B |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $1.1B |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $1.04B |
| Current Liabilities | Q2 2024 · Jun 30, 2023 | $1.53B |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $5.73B |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $6.3B |
| Total Liabilities | Q2 2024 · Jun 30, 2023 | $6.17B |
| Current Assets | Q2 2024 · Jun 30, 2024 | $2.92B |
| Current Assets | Q2 2024 · Dec 31, 2023 | $2.57B |
| Current Assets | Q2 2024 · Jun 30, 2023 | $2.69B |
| Total Assets | Q2 2024 · Jun 30, 2024 | $10.51B |
| Total Assets | Q2 2024 · Dec 31, 2023 | $9.99B |
| Total Assets | Q2 2024 · Jun 30, 2023 | $10.78B |
| Net Income | Q2 2024 · Mar 31, 2024 | −$965M |
| Net Income | Q2 2024 · Dec 31, 2023 | −$206M |
| Net Income | Q2 2024 · Dec 31, 2023 | −$965M |
| Net Income | Q2 2024 · Dec 31, 2022 | $81M |
| Net Income | Q2 2024 · Dec 31, 2022 | $81M |
| Shares Outstanding | Q2 2024 · Jan 31, 2024 | 180.74M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2023 | 182M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2023 | 181M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 181M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 181M sh |
| Capex | Q2 2024 · Dec 31, 2023 | $178M |
| Capex | Q2 2024 · Dec 31, 2022 | $317M |
| Operating Cash Flow | Q2 2024 · Dec 31, 2023 | $42M |
| Operating Cash Flow | Q2 2024 · Dec 31, 2022 | $122M |
| Short Term Debt | Q2 2024 · Dec 31, 2023 | $46M |
| Short Term Debt | Q2 2024 · Jun 30, 2023 | $536M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $229M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $280M |
| Eps Diluted | Q2 2024 · Dec 31, 2023 | −$1.13 |
| Eps Diluted | Q2 2024 · Dec 31, 2023 | −$5.31 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.44 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | $0.45 |
| Eps Basic | Q2 2024 · Dec 31, 2023 | −$1.13 |
| Eps Basic | Q2 2024 · Dec 31, 2023 | −$5.31 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.45 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | $0.45 |
| Sga Expense | Q2 2024 · Dec 31, 2023 | $250M |
| Sga Expense | Q2 2024 · Dec 31, 2023 | $455M |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $226M |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $422M |
| Rd Expense | Q2 2024 · Dec 31, 2023 | $4M |
| Rd Expense | Q2 2024 · Dec 31, 2023 | $8M |
| Rd Expense | Q2 2024 · Dec 31, 2022 | $9M |
| Operating Income | Q2 2024 · Dec 31, 2023 | −$112M |
| Operating Income | Q2 2024 · Dec 31, 2023 | −$838M |
| Operating Income | Q2 2024 · Dec 31, 2022 | $138M |
| Operating Income | Q2 2024 · Dec 31, 2022 | $198M |
| Gross Profit | Q2 2024 · Dec 31, 2023 | $171M |
| Gross Profit | Q2 2024 · Dec 31, 2023 | $340M |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $387M |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $645M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2023 | $853M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2023 | $1.67B |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $762M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $1.53B |
| Revenue | Q2 2024 · Dec 31, 2023 | $1.02B |
| Revenue | Q2 2024 · Dec 31, 2023 | $2.01B |
| Revenue | Q2 2024 · Dec 31, 2022 | $1.15B |
| Revenue | Q2 2024 · Dec 31, 2022 | $2.17B |